Conventional PCR systems require users to set a predetermined number of cycles based on assay- and sample-specific factors. When performing single-cell sequencing experiments, this requires knowledge ...
The FDA has cleared a multiplex polymerase chain reaction test designed to detect 11 clinically relevant gastrointestinal pathogens from a single stool sample.The Xpert GI Panel (Cepheid) can identify ...
The preimplantation genetic testing market is projected to surge from USD 690.2 million in 2025 to USD 1.13 billion by 2030, reflecting a robust CAGR of 10.5%. Key growth drivers include rising ...
You can get at-home medical tests for everything from Covid-19 to drug testing to hormone levels or food sensitivities. You can examine your gut, your blood, or even your DNA. At-home STI tests use ...
Mohal Sarabhai, CEO of CoSara, remarked, "We believe this landmark regulatory achievement validates the integrity of our quality management system, and that receiving this license for the PCR Pro will ...
Thankfully, most of us don’t easily recall the terrifying statistics that ruled our pandemic days before the COVID-19 vaccine became widely available. According to the Journal of the American Medical ...
Vaginal infections remain one of the most common yet frequently misdiagnosed reasons for gynecological consultations worldwide. Technology Networks spoke with Dr. Nico Michel, a lifecycle leader at ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR ...
Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results Today, Visby Medical announced two new relationships that will expand national access to the Visby ...
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from manufacturer Roche. The molecular test uses the cobas liat system and earned an ...
Roche has secured regulatory green lights in both the U.S. and Europe to begin shipping its first point-of-care test for whooping cough amid a worldwide surge in cases and the recent deaths of infants ...